Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors

Ruf, Theresa; Kramer, Rafaela; Forschner, Andrea; Leiter, Ulrike; Meier, Friedegund; Reinhardt, Lydia; Duecker, Pia; Ertl, Carolin; Tomsitz, Dirk; Tietze, Julia K.; Gutzmer, Ralf; Dabrowski, Evelyn; Zimmer, Lisa; Gesierich, Anja; Zierold, Sarah; French, Lars E.; Eigentler, Thomas; Amaral, Teresa; Heinzerling, Lucie

dc.contributor.author	Forschner, Andrea
dc.contributor.author	Leiter, Ulrike
dc.contributor.author	Amaral, Teresa
dc.date.accessioned	2025-02-04T11:58:39Z
dc.date.available	2025-02-04T11:58:39Z
dc.date.issued	2024
dc.identifier.issn	0959-8049
dc.identifier.uri	http://hdl.handle.net/10900/161619
dc.language.iso	en	de_DE
dc.publisher	London : Elsevier Sci Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.ejca.2024.114028	de_DE
dc.subject.ddc	610	de_DE
dc.title	Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors	de_DE
dc.type	Article	de_DE
utue.quellen.id	20241001000000_01862
utue.personen.roh	Ruf, Theresa
utue.personen.roh	Kramer, Rafaela
utue.personen.roh	Forschner, Andrea
utue.personen.roh	Leiter, Ulrike
utue.personen.roh	Meier, Friedegund
utue.personen.roh	Reinhardt, Lydia
utue.personen.roh	Duecker, Pia
utue.personen.roh	Ertl, Carolin
utue.personen.roh	Tomsitz, Dirk
utue.personen.roh	Tietze, Julia K.
utue.personen.roh	Gutzmer, Ralf
utue.personen.roh	Dabrowski, Evelyn
utue.personen.roh	Zimmer, Lisa
utue.personen.roh	Gesierich, Anja
utue.personen.roh	Zierold, Sarah
utue.personen.roh	French, Lars E.
utue.personen.roh	Eigentler, Thomas
utue.personen.roh	Amaral, Teresa
utue.personen.roh	Heinzerling, Lucie
dcterms.isPartOf.ZSTitelID	European Journal of Cancer	de_DE
dcterms.isPartOf.ZS-Issue	Article 114028	de_DE
dcterms.isPartOf.ZS-Volume	203	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE